Tetracycline Knocking the Door, Once Again


Vivek Sharma


This editorial highlights the hidden potentials of a long forgotten antibiotic tetracycline and urges the practioners to explore its clinical usefulness.


How to Cite
Sharma, V. (2014). Tetracycline Knocking the Door, Once Again. International Journal of Medical and Dental Sciences, 3(2), 386–387. https://doi.org/10.19056/ijmdsjssmes/2014/v3i2/81255


  1. Birkedal Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontal 1993;64:474.
  2. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr opin Periodontal 1996;3:85.
  3. Preshaw PM, Novase MJ, Mellonig J, Magnusson I, Polson A, Giannobile WV, et al. Modified release subantimicrobial dose doxycycline enhances scaling and root planning in subjects with periodontal disease. J Periodontal 2008;79(3):440-452.
  4. Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Kor J Ophthalmol 2005 Dec;19(4):258-63.
  5. Wang L, Tsang H, Coroneo M. Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid. Clin Exp Ophthalmol 2008 Feb;36(1):8-12.
  6. Liang D. Low-dose doxycycline in the treatment of corneal burn. Identifier: NCT01886560. Available at: http://clinicaltrials.gov/show/NCT01886560 . Accessed May 8, 2014.

Most read articles by the same author(s)